Serotonin–norepinephrine releasing agent
Source: Wikipedia, the free encyclopedia.
Drug class
Further information: serotonin releasing agent and norepinephrine releasing agent
A serotonin–norepinephrine releasing agent (SNRA) is a type of
epinephrine
) in the body and/or brain.
Only a few SNRAs are known, examples of which include
appetite suppressant for the treatment of obesity
.
A closely related type of drug is a serotonin–norepinephrine reuptake inhibitor (SNRI).
See also
- Monoamine releasing agent
- Serotonin releasing agent
- Norepinephrine releasing agent
- Serotonin–dopamine releasing agent
- Serotonin–norepinephrine–dopamine releasing agent
References
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TAAR1 |
| ||||||||||
| TAAR2 |
| ||||||||||
| TAAR5 |
| ||||||||||
† References for all endogenous human TAAR1 ligands are provided at List of trace amines
‡ References for synthetic TAAR1 agonists can be found at TAAR1 or in the associated compound articles. For TAAR2 and TAAR5 agonists and inverse agonists, see TAAR for references.
| |||||||||||
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |